Literature DB >> 1921997

Stimulation of ribosomal RNA synthesis during hypertrophic growth of cultured heart cells by phorbol ester.

T Haneda1, P J McDermott.   

Abstract

Primary cultures of neonatal cardiac myocytes were used to determine the effects of tumor-promoting phorbol esters on ribosomal RNA (rRNA) synthesis during myocyte growth. Treatment of myocytes with phorbol-12, 13-dibutyrate (PDBu) increased protein accumulation by 25% and RNA content by 20%. Rates of rRNA synthesis were measured to assess the mechanism by which rRNA accumulated during myocyte growth. Rates of rRNA synthesis were determined from the incorporation of [3H]uridine into UMP of purified rRNA and the specific radioactivity of the cellular UTP pool. After 24h of PDBu treatment, cellular rates of 18S and 28S rRNA synthesis were accelerated by 67% and 64%, respectively. The increased rate of rRNA synthesis accounted for the net increase in myocyte rRNA content after PDBu treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921997

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Improved microfluorometric DNA determination in biological material using 33258 Hoechst.

Authors:  C F Cesarone; C Bolognesi; L Santi
Journal:  Anal Biochem       Date:  1979-11-15       Impact factor: 3.365

2.  Insulin stimulates the translation of ribosomal proteins and the transcription of rDNA in mouse myoblasts.

Authors:  M L Hammond; L H Bowman
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

3.  Accelerated rates of ribosomal RNA synthesis during growth of contracting heart cells in culture.

Authors:  P J McDermott; L I Rothblum; S D Smith; H E Morgan
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

4.  Contraction modulates the capacity for protein synthesis during growth of neonatal heart cells in culture.

Authors:  P J McDermott; H E Morgan
Journal:  Circ Res       Date:  1989-03       Impact factor: 17.367

5.  Pyrimidine nucleotide synthesis in the normal and hypertrophying rat heart. Relative importance of the de novo and "salvage" pathways.

Authors:  S Matsushita; B L Fanburg
Journal:  Circ Res       Date:  1970-09       Impact factor: 17.367

Review 6.  Transcription of cloned eukaryotic ribosomal RNA genes.

Authors:  B Sollner-Webb; J Tower
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

7.  The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid.

Authors:  Y L Chan; R Gutell; H F Noller; I G Wool
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

8.  Differentiation of rat myoblasts. Regulation of turnover of ribosomal proteins and their mRNAs.

Authors:  F A Jacobs; R C Bird; B H Sells
Journal:  Eur J Biochem       Date:  1985-07-15

9.  Effects of thyroid hormone on UTP content and uridine kinase activity of rat heart and skeletal muscle.

Authors:  B J Gertz; E S Haugaard; N Haugaard
Journal:  Am J Physiol       Date:  1980-05

10.  The structure of rat 28S ribosomal ribonucleic acid inferred from the sequence of nucleotides in a gene.

Authors:  Y L Chan; J Olvera; I G Wool
Journal:  Nucleic Acids Res       Date:  1983-11-25       Impact factor: 16.971

View more
  2 in total

1.  Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor.

Authors:  J Fukuzawa; T Haneda; K Kikuchi
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

2.  Btg2 is a Negative Regulator of Cardiomyocyte Hypertrophy through a Decrease in Cytosolic RNA.

Authors:  Yuki Masumura; Shuichiro Higo; Yoshihiro Asano; Hisakazu Kato; Yi Yan; Saki Ishino; Osamu Tsukamoto; Hidetaka Kioka; Takaharu Hayashi; Yasunori Shintani; Satoru Yamazaki; Tetsuo Minamino; Masafumi Kitakaze; Issei Komuro; Seiji Takashima; Yasushi Sakata
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.